Most Popular
-
1
Actor Jung Woo-sung admits to being father of model Moon Ga-bi’s child
-
2
Wealthy parents ditch Korean passports to get kids into international school
-
3
Man convicted after binge eating to avoid military service
-
4
First snow to fall in Seoul on Wednesday
-
5
Final push to forge UN treaty on plastic pollution set to begin in Busan
-
6
Korea to hold own memorial for forced labor victims, boycotting Japan’s
-
7
S. Korea not to attend Sado mine memorial: foreign ministry
-
8
Nvidia CEO signals Samsung’s imminent shipment of AI chips
-
9
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
-
10
Job creation lowest on record among under-30s
South Korean shares opened higher on the back of positive progress in the development of the new coronavirus vaccines.
The benchmark Korea Composite Stock Price Index (KOSPI) rose 20.94 points, or 0.95 percent, to 2,219.14 in the first 15 minutes of trading.
Investor sentiment improved, following reports on the progress shown in early data for the three potential COVID-19 vaccine candidates.
Most large caps traded higher in Seoul.
Market bellwether Samsung Electronics added 1.48 percent, and No. 2 chipmaker SK hynix jumped 2.68 percent.
Top pharmaceutical firm Samsung BioLogics advanced 0.95 percent, with leading chemical maker LG Chem surging 3.13 percent.
The local currency was trading at 1197.85 won against the US dollar, up 5.35 won from the previous session's close. (Yonhap)
![[More than APT] Residents, architects together design homes](http://res.heraldm.com/phpwas/restmb_idxmake.php?idx=652&simg=/content/image/2024/11/24/20241124050036_0.jpg&u=)
